Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q1 2016 call → NOWe need answer YES or NO based on transcript. Need identify if management describes company currently living through defined waiting period paying out of pocket, with cost now, benefit not yet, end near-dated visible event, and main work. Let's examine transcript. Ed Breen talks about three critical initiatives: cost savings, working capital, capital expenditures. Also merger with Dow. He mentions "global cost savings and restructuring plan" with savings $1B run rate by year-end, net savings $730M for 2016. In Q1, costs down $135M. So they are already saving, not paying now for future benefit. Working capital improvements, CapEx reductions. Merger with Dow: integration planning underway, synergies expected. But merger not yet closed, costs? They mention "integration planning is well underway. We have formed a joint integration management office. Dow and DuPont are working directly together on plans to execute the merger, capture synergies and prepare for intended business separations." But do they describe paying costs now for future benefit? Not really. They mention "cost synergies" but not current costs. They mention "we have 27 teams focused on different categories of cost" but no mention of paying now. Agriculture: Jim Collins mentions "we are currently introducing varieties with Roundup Ready 2 Xtend technology in a very limited launch. While we didn’t plan for large volumes, this will allow our sales reps and customers to test the performance of these soybeans as we prepare for our full launch in 2017, pending regulatory approvals." That is a waiting period? They are paying for limited launch now, benefit full launch 2017. But is that described as real ongoing cost? Not really. Also "CRISPR-Cas advanced breeding technology within five years" - too far. Another: "LaPorte insecticide unit" shutdown, write-off and disposal of in-process inventory and dismantle facility. That is a cost, but it's a one-time impairment, not a waiting period for benefit. They say "unplanned cost as a result of our recent decision regarding the LaPorte insecticide unit from the write-off and disposal of in process inventory and to dismantle the facility." That's a cost from shutting down, not paying for future benefit. What about "global cost savings and restructuring plan" - they are paying severance costs now to get future savings.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.